Missed Opportunities for HIV Screening in General Practice

University Hospital, Strasbourg, France50 enrolled

Overview

The number of new HIV diagnoses in France in 2022 is estimated to be between 4,200 and 5,700. Of these diagnoses, 43% of infections were detected at a late stage. The objective of this study is to identify missed opportunities for HIV testing in general practice and to understand the barriers to testing.

Study Type

OBSERVATIONAL

Enrollment

Conditions

HIV Infections

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Adult subject (≥18 years) * diagnosed with HIV infection between January 1, 2021, and July 30, 2024 Exclusion Criteria: -Subject who arrived in France in the year preceding or during the period between January 1, 2024, and July 30, 2024.

Locations (1)

Service des Maladies Infectieuses et Tropicales - CHU de Strasbourg - France

Strasbourg, France

RECRUITING

Outcomes

Primary Outcomes

Presence or absence of clinical signs suggestive of HIV infection

This is a retrospective analysis of data on the presence or absence of clinical signs suggestive of HIV infection during the year preceding diagnosis

Time frame: 1 year preceding HIV diagnosis

Central Contacts

baptiste Hoellinger, MD

CONTACT

33 3 69 55 05 45 baptiste.hoellinger@chru-strasbourg.fr

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.